The hardware and bandwidth for this mirror is donated by dogado GmbH, the Webhosting and Full Service-Cloud Provider. Check out our Wordpress Tutorial.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]dogado.de.
replicateBE: Average Bioequivalence with Expanding Limits (ABEL)
Performs comparative bioavailability calculations for Average
Bioequivalence with Expanding Limits (ABEL). Implemented are 'Method A' /
'Method B' and the detection of outliers. If the design allows, assessment
of the empiric Type I Error and iteratively adjusting alpha to control the
consumer risk. Average Bioequivalence - optionally with a tighter (narrow
therapeutic index drugs) or wider acceptance range (South Africa: Cmax) -
is implemented as well.
| Version: |
1.1.3 |
| Depends: |
R (≥ 3.5.0) |
| Imports: |
readxl (≥ 1.0.0), PowerTOST (≥ 1.5.3), lmerTest, nlme, pbkrtest, graphics, grDevices |
| Suggests: |
knitr, rmarkdown, testthat, devtools |
| Published: |
2022-05-02 |
| Author: |
Helmut Schütz 
[aut, cre],
Michael Tomashevskiy [ctb],
Detlew Labes
[ctb] |
| Maintainer: |
Helmut Schütz <helmut.schuetz at bebac.at> |
| BugReports: |
https://github.com/Helmut01/replicateBE/issues |
| License: |
GPL (≥ 3) |
| URL: |
https://github.com/Helmut01/replicateBE |
| NeedsCompilation: |
no |
| Materials: |
README NEWS |
| In views: |
ClinicalTrials |
| CRAN checks: |
replicateBE results |
Documentation:
Downloads:
Linking:
Please use the canonical form
https://CRAN.R-project.org/package=replicateBE
to link to this page.
These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.
Health stats visible at Monitor.